Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

L

ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies…

Continue Reading


News Source: www.forbes.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *